What question did this study set out to answer?

The aim is to evaluate the effectiveness and persistence of different integrase strand transfer inhibitors in a real-world cohort.

March 10, 20260 citations

View Full Paper

Real-world use of second-generation integrase strand transfer inhibitors (INSTI) as switch therapy in the prospective ANRS-CO3-AquiVIH-NA cohort.

OLOlivier Leleux APA Peyrouny-Mazeau APAntoine PerrierCentre National de la Recherche Scientifique

Key Points

The aim is to evaluate the effectiveness and persistence of different integrase strand transfer inhibitors in a real-world cohort.
Conducted a prospective cohort analysis over 18 months
Examined treatment outcomes for B/F/TAF, DTG/RPV, DTG/3TC, and DTG/3TC/ABC
Assessed viral suppression and treatment persistence among participants
Treatment persistence at 18 months was similar for B/F/TAF, DTG/RPV, and DTG/3TC
DTG/3TC/ABC showed significantly lower treatment persistence
All regimens maintained high levels of viral suppression throughout the study

Abstract

In this real-world cohort, treatment persistence 18 months after therapy switch was similar for B/F/TAF, DTG/RPV and DTG/3TC, but significantly lower for DTG/3TC/ABC. All regimens maintained high levels of viral suppression. Furthermore, the cohort illustrates the disease burden experienced by middle-aged and elderly people living with HIV and highlights the importance of adapting ART to the specific needs of this population.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Leleux et al. (Sat,) studied this question.

synapsesocial.com/papers/69af950a70916d39fea4c274 https://doi.org/https://doi.org/10.1111/hiv.70220

Demander à l'IA

Bookmark

View Full Paper